Peter Calhoun

3.8k total citations
90 papers, 1.7k citations indexed

About

Peter Calhoun is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Peter Calhoun has authored 90 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Endocrinology, Diabetes and Metabolism, 55 papers in Surgery and 44 papers in Genetics. Recurrent topics in Peter Calhoun's work include Diabetes Management and Research (77 papers), Pancreatic function and diabetes (52 papers) and Diabetes and associated disorders (43 papers). Peter Calhoun is often cited by papers focused on Diabetes Management and Research (77 papers), Pancreatic function and diabetes (52 papers) and Diabetes and associated disorders (43 papers). Peter Calhoun collaborates with scholars based in United States, Canada and United Kingdom. Peter Calhoun's co-authors include Roy W. Beck, John W. Lum, Ryan Bailey, Craig Kollman, David M. Maahs, Bruce A. Buckingham, Richard M. Bergenstal, Darrell M. Wilson, David A. Price and H. Peter Chase and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Peter Calhoun

85 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Calhoun United States	24	1.5k	1.0k	949	80	72	90	1.7k
Tonya D. Riddlesworth United States	14	2.8k 1.9×	1.6k 1.6×	1.7k 1.8×	62 0.8×	104 1.4×	14	3.1k
J.C. Kuenen Netherlands	6	1.2k 0.8×	305 0.3×	398 0.4×	23 0.3×	137 1.9×	7	1.5k
Michele Aragona Italy	14	313 0.2×	256 0.3×	107 0.1×	27 0.3×	43 0.6×	36	760
Scott A. Pardo United States	15	780 0.5×	214 0.2×	214 0.2×	14 0.2×	73 1.0×	44	1000
Alicia Schiffrin Canada	21	970 0.7×	372 0.4×	421 0.4×	4 0.1×	58 0.8×	45	1.3k
Charles K. Botz Canada	10	482 0.3×	374 0.4×	218 0.2×	13 0.2×	28 0.4×	15	710
Torben Biester Germany	22	1.5k 1.0×	1.0k 1.0×	952 1.0×	11 0.1×	51 0.7×	77	1.7k
Revital Nimri Israel	25	2.1k 1.4×	1.8k 1.7×	1.5k 1.6×	8 0.1×	56 0.8×	50	2.4k
Robert H. Slover United States	21	2.2k 1.5×	1.7k 1.7×	1.5k 1.6×	9 0.1×	57 0.8×	36	2.4k

Countries citing papers authored by Peter Calhoun

Since Specialization

Citations

This map shows the geographic impact of Peter Calhoun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Calhoun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Calhoun more than expected).

Fields of papers citing papers by Peter Calhoun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Calhoun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Calhoun. The network helps show where Peter Calhoun may publish in the future.

Co-authorship network of co-authors of Peter Calhoun

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Calhoun. A scholar is included among the top collaborators of Peter Calhoun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Calhoun. Peter Calhoun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Calhoun, Peter, et al.. (2025). Real-World Clinical Impact of Using Personal Glucose Targets in a Hybrid Closed-Loop System Differs According to Age. Diabetes Technology & Therapeutics. 28(2). 167–174.

Calhoun, Peter, Andrea K. Steck, Brigitte I. Frohnert, et al.. (2025). Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes development. Diabetologia. 68(5). 930–939.

Tillman, John B., Roy W. Beck, William H. Polonsky, et al.. (2024). Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A 6-Month Analysis. The Journal of Clinical Endocrinology & Metabolism. 110(8). 2134–2146. 1 indexed citations

Gal, Robin L., Peter Calhoun, Zoey Li, et al.. (2024). Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort. Diabetologia. 67(6). 1009–1022. 2 indexed citations

Boughton, Charlotte K., Janet M. Allen, Julia Ware, et al.. (2024). The effect of closed-loop glucose control on C-peptide secretion in youth with newly diagnosed type 1 diabetes: the CLOuD RCT. SHILAP Revista de lepidopterología. 1–75.

Li, Zoey, Robin L. Gal, Jessica R. Castle, et al.. (2024). Effect of Impaired Awareness of Hypoglycemia on Glucose Decline During and After Exercise in the T1DEXI Study. The Journal of Clinical Endocrinology & Metabolism. 109(9). 2233–2241. 2 indexed citations

Riddell, Michael C., Peter G. Jacobs, Zoey Li, et al.. (2023). The Type 1 Diabetes and EXercise Initiative: Predicting Hypoglycemia Risk During Exercise for Participants with Type 1 Diabetes Using Repeated Measures Random Forest. Diabetes Technology & Therapeutics. 25(9). 602–611. 12 indexed citations

Chao, Christy, et al.. (2023). Assessing non‐adjunctive CGM safety at home and in new markets (ANSHIN). Endocrinology Diabetes & Metabolism. 6(3). e414–e414. 4 indexed citations

Beck, Roy W., Dan Raghinaru, Peter Calhoun, & Richard M. Bergenstal. (2023). A Comparison of Continuous Glucose Monitoring-Measured Time-in-Range 70–180 mg/dL Versus Time-in-Tight-Range 70–140 mg/dL. Diabetes Technology & Therapeutics. 26(3). 151–155. 39 indexed citations

10.

Calhoun, Peter, et al.. (2023). Testing the Real-World Accuracy of the Dexcom G6 Pro CGM During the Insulin-Only Bionic Pancreas Pivotal Trial. Diabetes Technology & Therapeutics. 25(11). 817–821. 6 indexed citations

11.

Lal, Rayhan, Stefanie Lanzinger, Kellee M. Miller, et al.. (2022). Temporal Changes in Hemoglobin A1c and Diabetes Technology Use in DPV, NPDA, and T1DX Pediatric Cohorts from 2010 to 2018. Diabetes Technology & Therapeutics. 24(9). 628–634. 9 indexed citations

12.

Boughton, Charlotte K., Janet M. Allen, Julia Ware, et al.. (2022). Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes. New England Journal of Medicine. 387(10). 882–893. 57 indexed citations

13.

Messer, Laurel H., Bruce A. Buckingham, Fran R. Cogen, et al.. (2022). Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6–17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial. Diabetes Technology & Therapeutics. 24(10). 712–725. 29 indexed citations

14.

Beck, Roy W., Dan Raghinaru, Peter Calhoun, & Richard M. Bergenstal. (2022). The Relationship Between Percent Time <70 mg/dL and Percent Time <54 mg/dL Measured by Continuous Glucose Monitoring. Diabetes Technology & Therapeutics. 25(3). 157–160. 2 indexed citations

15.

Albanese-O’Neill, Anastasia, Julia M. Grimsmann, Ann‐Marie Svensson, et al.. (2021). Changes in HbA1c Between 2011 and 2017 in Germany/Austria, Sweden, and the United States: A Lifespan Perspective. Diabetes Technology & Therapeutics. 24(1). 32–41. 18 indexed citations

16.

Bailey, Ryan, Peter Calhoun, Christy Chao, & Tomas C. Walker. (2021). With or Without Residual C-Peptide, Patients with Type 2 Diabetes Realize Glycemic Benefits from Real-Time Continuous Glucose Monitoring. Diabetes Technology & Therapeutics. 24(4). 281–284. 1 indexed citations

17.

Cafri, Guy, Stephen E. Graves, Art Sedrakyan, et al.. (2019). Postmarket surveillance of arthroplasty device components using machine learning methods. Pharmacoepidemiology and Drug Safety. 28(11). 1440–1447. 8 indexed citations

18.

Price, Marianne O., Peter Calhoun, Craig Kollman, Francis W. Price, & Jonathan H. Lass. (2016). Descemet Stripping Endothelial Keratoplasty. Ophthalmology. 123(7). 1421–1427. 73 indexed citations

19.

Kollman, Craig, Peter Calhoun, John W. Lum, William H. Sauer, & Roy W. Beck. (2013). Evaluation of Stochastic Adjustment for Glucose Sensor Bias During Closed-Loop Insulin Delivery. Diabetes Technology & Therapeutics. 16(3). 186–192. 4 indexed citations

20.

Cameron, Fraser, Darrell M. Wilson, Bruce A. Buckingham, et al.. (2012). Inpatient studies of a Kalman-filter-based predictive pump shutoff algorithm. Diabetes Technology & Therapeutics. 16. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact